Human Mucosal IgA Immune Responses Against Enterotoxigenic

Overview

Journal Pathogens

Date 2020 Sep 3

PMID 32872549

Citations 5

Authors

Saman Riaz

Hans Steinsland

Kurt Hanevik

Affiliations

Soon will be listed here.

Abstract

Infection with enterotoxigenic (ETEC) is a major contributor to diarrheal illness in children in low- and middle-income countries and travelers to these areas. There is an ongoing effort to develop vaccines against ETEC, and the most reliable immune correlate of protection against ETEC is considered to be the small intestinal secretory IgA response that targets ETEC-specific virulence factors. Since isolating IgA from small intestinal mucosa is technically and ethically challenging, requiring the use of invasive medical procedures, several other indirect methods are used as a proxy for gauging the small intestinal IgA responses. In this review, we summarize the literature reporting on anti-ETEC human IgA responses observed in blood, activated lymphocyte assayss, intestinal lavage/duodenal aspirates, and saliva from human volunteers being experimentally infected with ETEC. We describe the IgA response kinetics and responder ratios against classical and noncanonical ETEC antigens in the different sample types and discuss the implications that the results may have on vaccine development and testing.

Citing Articles

Proportions of IgA antibodies targeting glycosylated epitopes of secreted Escherichia coli mucinase YghJ in initial plasmablast response differ from salivary and intestinally secreted IgA.

Riaz S, Steinsland H, Andersen A, Boysen A, Hanevik K Med Microbiol Immunol. 2024; 214(1):2.

PMID: 39673573 PMC: 11646272. DOI: 10.1007/s00430-024-00812-0.

Role of cellular effectors in the induction and maintenance of IgA responses leading to protective immunity against enteric bacterial pathogens.

Carreto-Binaghi L, Sztein M, Booth J Front Immunol. 2024; 15:1446072.

PMID: 39324143 PMC: 11422102. DOI: 10.3389/fimmu.2024.1446072.

Development of a new candidate vaccine against piglet diarrhea caused by .

Xu C, Fu F, She Y, Yang D, Peng K, Lin Y Open Life Sci. 2024; 18(1):20220804.

PMID: 38196514 PMC: 10775170. DOI: 10.1515/biol-2022-0804.

Dual-Use Vaccine for Diarrhoeal Diseases: Cross-Protective Immunogenicity of a Cold-Chain-Free, Live-Attenuated, Oral Cholera Vaccine against Enterotoxigenic (ETEC) Challenge in BALB/c Mice.

Hui Xian T, Parasuraman S, Ravichandran M, Prabhakaran G Vaccines (Basel). 2022; 10(12).

PMID: 36560571 PMC: 9787504. DOI: 10.3390/vaccines10122161.

The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections.

Richards A, Baranova D, Mantis N Hum Vaccin Immunother. 2021; 18(2):1964317.

PMID: 34491878 PMC: 9103515. DOI: 10.1080/21645515.2021.1964317.

References

Vedoy O, Hanevik K, Sakkestad S, Sommerfelt H, Steinsland H . Proliferation of enterotoxigenic strain TW11681 in stools of experimentally infected human volunteers. Gut Pathog. 2018; 10:46. PMC: 6192177. DOI: 10.1186/s13099-018-0273-6. View

Jertborn M, Svennerholm A, Holmgren J . Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease. J Clin Microbiol. 1986; 24(2):203-9. PMC: 268875. DOI: 10.1128/jcm.24.2.203-209.1986. View

Roy K, Bartels S, Qadri F, Fleckenstein J . Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins. Infect Immun. 2010; 78(7):3027-35. PMC: 2897383. DOI: 10.1128/IAI.00264-10. View

Kantele A, Arvilommi H, Jokinen I . Specific immunoglobulin-secreting human blood cells after peroral vaccination against Salmonella typhi. J Infect Dis. 1986; 153(6):1126-31. DOI: 10.1093/infdis/153.6.1126. View

Luo Q, Qadri F, Kansal R, Rasko D, Sheikh A, Fleckenstein J . Conservation and immunogenicity of novel antigens in diverse isolates of enterotoxigenic Escherichia coli. PLoS Negl Trop Dis. 2015; 9(1):e0003446. PMC: 4309559. DOI: 10.1371/journal.pntd.0003446. View

Kuhlmann F, Martin J, Hazen T, Vickers T, Pashos M, Okhuysen P . Conservation and global distribution of non-canonical antigens in Enterotoxigenic Escherichia coli. PLoS Negl Trop Dis. 2019; 13(11):e0007825. PMC: 6897418. DOI: 10.1371/journal.pntd.0007825. View

Roy K, Hilliard G, Hamilton D, Luo J, Ostmann M, Fleckenstein J . Enterotoxigenic Escherichia coli EtpA mediates adhesion between flagella and host cells. Nature. 2008; 457(7229):594-8. PMC: 2646463. DOI: 10.1038/nature07568. View

McKenzie R, Darsley M, Thomas N, Randall R, Carpenter C, Forbes E . A double-blind, placebo-controlled trial to evaluate the efficacy of PTL-003, an attenuated enterotoxigenic E. coli (ETEC) vaccine strain, in protecting against challenge with virulent ETEC. Vaccine. 2008; 26(36):4731-9. DOI: 10.1016/j.vaccine.2008.06.064. View

Chakraborty S, Harro C, DeNearing B, Ram M, Feller A, Cage A . Characterization of Mucosal Immune Responses to Enterotoxigenic Escherichia coli Vaccine Antigens in a Human Challenge Model: Response Profiles after Primary Infection and Homologous Rechallenge with Strain H10407. Clin Vaccine Immunol. 2015; 23(1):55-64. PMC: 4711095. DOI: 10.1128/CVI.00617-15. View

10.

Kumar P, Luo Q, Vickers T, Sheikh A, Lewis W, Fleckenstein J . EatA, an immunogenic protective antigen of enterotoxigenic Escherichia coli, degrades intestinal mucin. Infect Immun. 2014; 82(2):500-8. PMC: 3911389. DOI: 10.1128/IAI.01078-13. View

11.

Evans D, Evans Jr D, Opekun A, Graham D . Non-replicating oral whole cell vaccine protective against enterotoxigenic Escherichia coli (ETEC) diarrhea: stimulation of anti-CFA (CFA/I) and anti-enterotoxin (anti-LT) intestinal IgA and protection against challenge with ETEC belonging to.... FEMS Microbiol Immunol. 1988; 1(3):117-25. DOI: 10.1111/j.1574-6968.1988.tb02363.x. View

12.

Savarino S, McKenzie R, Tribble D, Porter C, ODowd A, Cantrell J . Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial. J Infect Dis. 2017; 216(1):7-13. DOI: 10.1093/infdis/jix144. View

13.

DuPont H, Formal S, Hornick R, Snyder M, Libonati J, Sheahan D . Pathogenesis of Escherichia coli diarrhea. N Engl J Med. 1971; 285(1):1-9. DOI: 10.1056/NEJM197107012850101. View

14.

Spencer J, Sollid L . The human intestinal B-cell response. Mucosal Immunol. 2016; 9(5):1113-24. DOI: 10.1038/mi.2016.59. View

15.

Johansen F, Baekkevold E, Carlsen H, Farstad I, Soler D, Brandtzaeg P . Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils. Blood. 2005; 106(2):593-600. DOI: 10.1182/blood-2004-12-4630. View

16.

Hazen T, Nagaraj S, Sen S, Permala-Booth J, Del Canto F, Vidal R . Genome and Functional Characterization of Colonization Factor Antigen I- and CS6-Encoding Heat-Stable Enterotoxin-Only Enterotoxigenic Reveals Lineage and Geographic Variation. mSystems. 2019; 4(1). PMC: 6446980. DOI: 10.1128/mSystems.00329-18. View

17.

Wolf M . Occurrence, distribution, and associations of O and H serogroups, colonization factor antigens, and toxins of enterotoxigenic Escherichia coli. Clin Microbiol Rev. 1997; 10(4):569-84. PMC: 172934. DOI: 10.1128/CMR.10.4.569. View

18.

Levine M, Caplan E, Waterman D, Cash R, Hornick R, Snyder M . Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun. 1977; 17(1):78-82. PMC: 421084. DOI: 10.1128/iai.17.1.78-82.1977. View

19.

Seo H, Lu T, Nandre R, Duan Q, Zhang W . Immunogenicity characterization of genetically fused or chemically conjugated heat-stable toxin toxoids of enterotoxigenic Escherichia coli in mice and pigs. FEMS Microbiol Lett. 2019; 366(4). PMC: 6420877. DOI: 10.1093/femsle/fnz037. View

20.

Chakraborty S, Randall A, Vickers T, Molina D, Harro C, DeNearing B . Human Experimental Challenge With Enterotoxigenic Escherichia coli Elicits Immune Responses to Canonical and Novel Antigens Relevant to Vaccine Development. J Infect Dis. 2018; 218(9):1436-1446. PMC: 6151082. DOI: 10.1093/infdis/jiy312. View